Prevtec microbia in the headlines...
Prevtec microbia enters into international agreement with Virbac
Virbac, the 8th largest veterinarian pharmaceutical group worldwide, becomes Prevtec microbia's exclusive distributor for the Coliprotec® vaccine in Brazil, which is the third largest producer of pork in the world.
Some specialized press coverage:
Pig Progress
Biotech Intelligence
Silo Breaker
BioSpace
Genetic Engineering & Biotechnology News
Bio Portfolio
Biotechnology News Today
Red Orbit
Canadian Business
Bloomberg et Bloomberg Businessweek
Yahoo! Finance
The Street
Morningstar
AlphaTrade Finance
Finanz Nachrichten
Congoo
Sys-Con Media
World News
Pig Progress Biotech Intelligence Silo Breaker BioSpace Genetic Engineering & Biotechnology News Bio Portfolio Biotechnology News Today Red Orbit Canadian Business Bloomberg et Bloomberg Businessweek Yahoo! Finance The Street Morningstar AlphaTrade Finance Finanz Nachrichten Congoo Sys-Con Media World News
The press release issued on March 28, 2011 through CNW/Telbec and PR Newswire has rapidly gone round the world.
Every major US network reported the news: NBC, CBS, ABC, Fox and it was republished from Vermont to Texas, from Carolina to California, and even in Hawaii.
Virbac simultaneously issued a press release in Europe and the information spread all the way to India.
Most importantly, the news was warmly reported in the industry press as in technology and business media, as exemplified by the list on the left.
Indeed, this international distribution agreement with one of the major pharmaceutical groups in the world validates the quality of the work of our research team at Prevtec, which started operations only 5 years ago.
Every major US network reported the news: NBC, CBS, ABC, Fox and it was republished from Vermont to Texas, from Carolina to California, and even in Hawaii.
Virbac simultaneously issued a press release in Europe and the information spread all the way to India.
Most importantly, the news was warmly reported in the industry press as in technology and business media, as exemplified by the list on the left.
Indeed, this international distribution agreement with one of the major pharmaceutical groups in the world validates the quality of the work of our research team at Prevtec, which started operations only 5 years ago.
Prevtec microbia wins a prestigious GENESIS award
Started by BIOQuebec in 2001, the Genesis Awards recognize entrepreneurship, innovation and technology transfer achieved by Québec companies and also honour preeminent individuals amongst the personalities who have played a key role in the growth of Quebec’s life sciences industry.Prevtec microbia received the 2008 Genesis Award in the category of Transfer - Emergence, at the 8th Genesis Gala held in Montreal on April 16, 2008 at the Biomedex convention and exhibition. The Transfer - Emergence Award is given to a company and its founding officers who have successfully implemented a technology transfer process.
Prevtec stood out by demonstrating the innovative nature of its Coliprotec vaccine, a technology derived from an academic research program, as well as its managerial, financial and scientific expertise.
Coliprotec Vaccine Launching Ceremony video - 2 min